-
Mashup Score: 0NIH RECOVER - 1 year(s) ago
The National Institutes of Health (NIH) created the RECOVER Initiative to learn about the long-term effects of COVID. Everyone can join the search for answers to Long COVID. Whether or not you have had COVID, you may be able to participate in RECOVER research.
For more information go to https://recovercovid.org/news-events
Source: NIH VideoCastingCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Are you a senior scientist seeking a leadership career at one of the world’s preeminent biomedical research institutes? The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) is seeking exceptional candidates for the position of Deputy Director, Center for Translation Research and Implementation Science (CTRIS).
Source: Office of Human ResourcesCategories: Hem/Oncs, Latest HeadlinesTweet-
.@NIH_NHLBI: #CTRIS. We are hiring! Exciting opportunity for scientific & managerial leadership in an integrated program of translational, clinical, and implementation research. #GlobalHealth #ImpSci #Disparities #NIH_CEAL https://t.co/Xe9B9Dv2gl https://t.co/HASKvjVDVC
-
-
Mashup Score: 0Clinical Characteristics and Outcomes Among Adults ... - 2 year(s) ago
This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.
Categories: Hem/Oncs, Latest HeadlinesTweet-
.#CDC: Among adults hospitalized with #SARSCoV2 infection during #Omicron predominance, #COVID19 #vaccination, including with a #booster dose, was associated with lower likelihood of intensive care unit admission. #VaccinesWork #ICU #death #MMWR https://t.co/pu7zAWunoD #NIH_CEAL https://t.co/Cu7X8Cvb9Z
-
-
Mashup Score: 0Stay Up-to-Date on Federal Vaccine and Other COVID-19 Guidelines - 2 year(s) ago
FREE COVID-19 rapid antigen tests available to order Starting today, Jan.19, community members can order up to four at-home rapid COVID-19 tests for free! The COVIDtests.gov program will ensure broad access to at-home tests to those who request them. Tests…
Categories: Hem/Oncs, Latest HeadlinesTweet-
The #NIHCEAL newsletter will help you stay current with updates on #community engagement and outreach efforts on the #COVID19 pandemic. #partnerships #CBO #TipSheets Promising Practices. https://t.co/bFv6P07nF3 #NIH_CEAL https://t.co/rRWzHwwoYJ
-
-
Mashup Score: 21Do vaccines protect from long COVID? - 2 year(s) ago
On Jan 6, 2022, the UK Government’s Office of National Statistics (ONS) published their latest report on the prevalence of long COVID in the UK from a representative survey. As of Dec 6, 2021, around 1·266 million people living in the UK had self-reported long COVID (95% CI 1·228–1·304; 2% of the total population), defined as symptoms persisting for more than 4 weeks after the first confirmed or…
Source: The Lancet Respiratory MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Do #vaccines protect from long COVID? A case-control study of 1·2 million users of a #COVID19 symptom tracker app in UK showed that the risk of developing #LongCovid was reduced by about 50% in those who were double vaccinated. #VaccinesWork @NIH https://t.co/EyZfMiaQjf #NIH_CEAL https://t.co/I0Qrp7lX16
-
-
Mashup Score: 0Coronavirus (COVID-19) Update: FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine - 2 year(s) ago
The FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to take several actions that will expand the use of the vaccine in certain populations.
Categories: Hem/Oncs, Latest HeadlinesTweet-
.#FDA expands use of @Pfizer #COVID19 #vaccine: 1. Single booster approved for kids 12-15 yrs. 2. ⬇️time between primary Pfizer vax and booster to at least 5 months. 3. Approved third primary series dose for some immunocompromised kids 5-11 yrs. https://t.co/RsUOZhtE9o #NIH_CEAL https://t.co/pZ3S9Gqr5b
-
-
Mashup Score: 0Influenza Vaccination Increased During the COVID-19 Pandemic - 2 year(s) ago
Last year’s efforts by public health authorities to ward off a “twindemic” of COVID-19 and influenza appear to have paid off in the form of increased flu vaccinations, according to a CDC report.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.#CDC: Good news. Data from 10 states and #NYC: Overall, #flu #vaccinations ⬆️by 9% during the last quarter of 2020 compared with same period in 2018 & 2019. Increase in vax doses: Adolescents: 13% Adults 18-64: 15% Adults 65+: 9.5% #VaccinesWork #NIH_CEAL https://t.co/4cMrEqZQ0Q https://t.co/A1MmLSujdv
-
-
Mashup Score: 0Community Engagement Teams | Community Engagement Alliance - 2 year(s) ago
CEAL in Communities Image …
Source: Community Engagement AllianceCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NIH_CEAL teams engage #communities in states across the #USA. Using their existing relationships & fostering new ones, #CEAL teams work closely with #community leaders & organizations to address #MISINFORMATION about #COVID19 & mistrust of #science. Read https://t.co/pkcG0TrwZj https://t.co/n4GSdR2sPB
-
-
Mashup Score: 9Texas Children’s Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India - 2 year(s) ago
Texas Children’s Hospital and Baylor College of Medicine COVID-19 Vaccine Technology Secures Emergency Use Authorization in India Mass Distribution of “The World’s COVID-19 Vaccine” to be Deployed to India with Other Underserved Countries to Follow HOUSTON, TX (December 28, 2021) – Texas Children’s Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit…
Source: www.texaschildrens.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Dr. @PeterHotez: @TexasChildrens Hospital and @BCM_TropMed form partnership with @Biological_e to vaccinate the world beginning in #India with other underserved countries to follow. #COVID19 #SARSCoV2 #LMICs @Fogarty @NIAID @USAID @Baylor https://t.co/D5DQsNOaVF #NIH_CEAL https://t.co/XGQguVZ5Ug
-
-
Mashup Score: 0Texas Children’s Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India - 2 year(s) ago
Texas Children’s Hospital and Baylor College of Medicine COVID-19 Vaccine Technology Secures Emergency Use Authorization in India Mass Distribution of “The World’s COVID-19 Vaccine” to be Deployed to India with Other Underserved Countries to Follow HOUSTON, TX (December 28, 2021) – Texas Children’s Hospital and Baylor College of Medicine announced today that CORBEVAX™, a protein sub-unit…
Source: www.texaschildrens.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Dr. @PeterHotez: @TexasChildrens Hospital and @BCM_TropMed form partnership with @Biological_e to vaccinate the world beginning in #Ind with other underserved countries to follow. #COVID19 #SARSCoV2 #LMICs @Fogarty @NIAID @Baylor https://t.co/D5DQsNOaVF #NIH_CEAL https://t.co/QjQpKINjuk
-
.#NIHCEAL: There have been successes in #Tribal communities in addressing the #COVID19 pandemic. Please join members of the #RECOVERcovid Initiative, #NIH_CEAL and @NIH THRO for a webinar on highlights of these successes. December 7at 2pm EST. Watch live: https://t.co/P1Cl9Xyung https://t.co/3jlAkGKy2v